IL-6 signalling pathway inactivation with siltuximab in patients with COVID-19 respiratory failure: an observational cohort study

Giuseppe Gritti, Federico Raimondi, Diego Ripamonti, Ivano Riva, Francesco Landi, Leonardo Alborghetti, Marco Frigeni, Marianna Damiani, Caterina Micò, Stefano Fagiuoli, Roberto Cosentini, Ferdinando Luca Lorini, Lucia Gandini, Luca Novelli, Jonathan P Morgan, Benjamin M J Owens, Karan J K Kanhai, Gordana Tonkovic Reljanovic, Marco Rizzi, Fabiano Di Marco, Alessandro Rambaldi
doi: https://doi.org/10.1101/2020.04.01.20048561
Back to top
Posted June 20, 2020.
Download PDF

Supplementary Material

Data/Code
Email
IL-6 signalling pathway inactivation with siltuximab in patients with COVID-19 respiratory failure: an observational cohort study
Giuseppe Gritti, Federico Raimondi, Diego Ripamonti, Ivano Riva, Francesco Landi, Leonardo Alborghetti, Marco Frigeni, Marianna Damiani, Caterina Micò, Stefano Fagiuoli, Roberto Cosentini, Ferdinando Luca Lorini, Lucia Gandini, Luca Novelli, Jonathan P Morgan, Benjamin M J Owens, Karan J K Kanhai, Gordana Tonkovic Reljanovic, Marco Rizzi, Fabiano Di Marco, Alessandro Rambaldi
medRxiv 2020.04.01.20048561; doi: https://doi.org/10.1101/2020.04.01.20048561
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area